ic502942a_si_003.cif (629.57 kB)
H2CHXdedpa and H4CHXoctapaChiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals
dataset
posted on 2015-02-16, 00:00 authored by Caterina F. Ramogida, Jacqueline F. Cawthray, Eszter Boros, Cara L. Ferreira, Brian O. Patrick, Michael J. Adam, Chris OrvigThe chiral acyclic ligands H2CHXdedpa (N4O2), H2CHXdedpa-bb (N4O2),
and H4CHXoctapa (N4O4) (CHX = cyclohexyl/cyclohexane, H2dedpa
= 1,2-[[6-carboxy-pyridin-2-yl]-methylamino]ethane, bb = N,N′-dibenzylated, H4octapa = N,N′-bis(6-carboxy-2-pyridylmethyl)-ethylenediamine-N,N′-diacetic acid) were synthesized,
complexed with Ga(III) and/or In(III), and evaluated for their potential
as chelating agents in radiopharmaceutical applications. The ligands
were compared to the previously studied hexadentate H2dedpa
and octadentate H4octapa ligands to determine the effect
adding a chiral 1R,2R-trans-cyclohexane to replace the ethylenediamine backbone would have on
metal complex stability and radiolabeling kinetics. It was found that
[Ga(CHXdedpa)]+ showed very similar properties
to those of [Ga(dedpa)]+, with only one isomer in solution
observed by NMR spectroscopy, and minimal structural changes in the
solid-state X-ray structure. Like [Ga(dedpa)]+, [Ga(CHXdedpa)]+ exhibited exceptionally high thermodynamic
stability constants (log KML = 28.11(8)),
and the chelate retained the ability to label 67Ga quantitatively
in 10 min at room temperature at ligand concentrations of 1 ×
10–5 M. In vitro kinetic inertness assays demonstrated
the [67Ga(CHXdedpa)]+ complex
to be more stable than [67Ga(dedpa)]+ in a human
serum competition, with 90.5% and 77.8% of 67Ga remaining
chelate-bound after 2 h, respectively. Preliminary coordination studies
of H4CHXoctapa with In(III) demonstrated
[In(CHXoctapa)]− to have an equivalently
high thermodynamically stable constant as [In(octapa)]−, with log KML values of 27.16(9) and
26.76(14), respectively. The [111In(CHXoctapa)]− complex showed exceptionally high in
vitro kinetic inertness over 120 h in human serum, comparing well
with previously reported [111In(octapa)]− values, and an improved stability compared to the current industry
“gold standards” 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic
acid (DOTA) and diethylenetriaminepentaacetic acid (DTPA). Initial
investigations reveal that the chiral acyclic hexadentate H2CHXdedpa and octadentate H4CHXoctapa ligands are ideal candidates for radiopharmaceutical elaboration
of gallium or indium isotopes, respectively.
History
Usage metrics
Categories
Keywords
hexadentate H 2 dedpa2 h67 Galog K ML valueschelating agentsinertness assays10 minH 4 octapastability constantsInitial investigationslabel 67 Gaoctadentate H 4 octapa ligandsDOTAlog K MLdiethylenetriaminepentaacetic acidligand concentrationsh 2 CHX dedpachiral acyclic hexadentate H 2 CHX dedparadiolabeling kinetics120 hindium isotopesH 4 CHX octapaserum competitionDTPAPreliminary coordination studieschiral acyclic ligands H 2 CHX dedpaNMR spectroscopyoctadentate H 4 CHX octapa ligandsethylenediamine backboneN 4 O 4room temperature
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC